-
Mashup Score: 0BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes - 2 day(s) ago
May 2, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the primary endpoint results of the open label roll-in cohort of the CardiAMP Cell Therapy in Chronic Myocardial Ischemia Trial. Study clinical cardiology leadership and members of the Executive Steering Committee, Dr. Carl Pepine, Professor of Medicine at the University Florida at Gainesville, and Dr. Amish Raval, Professor of Medicine at the University of Wisconsin at Madison, presented the early positive results on Tuesday, April 30, 2024 in a webcast sponsored by BioCardia. Results from the open label roll-in cohort of patients having chronic myocardial ischemia with refractory angina showed an average increase in exercise tolerance of 107 seconds and an average of 82% reduction in angina episodes at the primary six-month follow-up endpoint compared to before receiving the study treatment. All of the patients responded posi
Source: www.dicardiology.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1
May 2, 2024 — Artificial intelligence experts at Cedars-Sinai and the Smidt Heart Institute created a dataset with more than 1 million echocardiograms, or cardiac ultrasound videos, and their corresponding clinical interpretations. Using this database, they created EchoCLIP, a powerful machine learning algorithm that can “interpret” echocardiogram images and assess key findings. The design and evaluation of EchoCLIP, described in a manuscript published in the peer-reviewed journal Nature Medicine, suggest that an EchoCLIP interpretation of a patient’s echocardiogram provides clinician-level evaluations of heart function, assessment of past surgeries and devices, and may assist clinicians in identifying patients in need of treatment. The EchoCLIP foundation model also can identify the same patient across multiple videos, studies and timepoints as well as recognize clinically important changes in a patient’s heart. “To our knowledge, this is the largest model trained on echocardiograp
Source: www.dicardiology.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1
May 1, 2024 — The annual Society for Cardiovascular Angiography & Interventions (SCAI) kicks off its SCAI Scientific Sessions 2024 this week, May 2-4 in Long Beach, CA, and organizers report the annual meeting will bring together more than 1,800 clinicians, scientists, researchers, and innovators in the field of interventional cardiology and endovascular medicine. “We are proud to offer over 80 sessions in a variety of interactive educational formats at this year’s meeting. We believe the tools, resources, and information shared at the meeting will provide the healthcare community with greater expertise to improve patient outcomes and also connect with their interventional cardiology colleagues,” said SCAI President George D. Dangas, MD, PhD, MSCAI, Icahn School of Medicine – Mt. Sinai Hospital (New York, NY). Presenting the latest cutting-edge advances in cardiovascular research, prevention, and care will be 500+ faculty, nearly 450 abstracts presenting the latest clinical data, proce
Source: www.dicardiology.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
May 1, 2024 — A study in more than 3,000 US counties, with 315 million residents, has suggested that air pollution is linked with stress and depression, putting under-65-year-olds at increased risk of dying from cardiovascular disease. The research is presented today at ESC Preventive Cardiology 2024, a scientific congress of the European Society of Cardiology (ESC).1 “Our study indicates that the air we breathe affects our mental well-being, which in turn impacts heart health,” said study lead author Dr. Shady Abohashem of Harvard Medical School, Boston, US. According to the World Health Organization, air pollution is estimated to have caused 4.2 million premature deaths worldwide in 2019.2 Mental illness has also been linked with premature death.3 This study examined whether air pollution and poor mental health are interrelated and have a joint impact on death from cardiovascular disease. The study focused on particles less than 2.5 micrometres in diameter, also referred to as fine p
Source: www.dicardiology.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Fully-automated One-click On-site CT-FFR: a Novel Tool for Functional Evaluation for Patients with Coronary Artery Disease - 6 day(s) ago
May 1, 2024 —In this 3-stage study, 3 cohorts were used for diagnostic performance, and prognostic performance evaluation for this fully automated, one-click, on-site CT-FFR technique. This study was led by Professors Long Jiang Zhang and Guang Ming Lu (Department of Radiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University). In cohort 1, a total of 463 patients and 600 coronary vessels with CCTA images and following invasive fractional flow reserve (FFR) results were collected for diagnostic performance and user-friendliness evaluation. CT-FFR had a strong correlation with invasive FFR both on a per-vessel basis and per-patient basis (Pearson R = 0.68, 95% CI: 0.63–0.72 and Pearson R = 0.70, 95% CI: 0.65–0.75, P 0.80) both in participants with chronic coronary syndromes and ones with acute chest pain. This is the first reported fully-automatic CT-FFR technique, and demonstrated similar diagnostic performance compared to HeartFlow and Siemens CT-FFR techniq
Source: www.dicardiology.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0ChatGPT Extracts Data for Ischaemic Stroke Almost Perfectly - 6 day(s) ago
May 1, 2024 — In an ischemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must therefore act quickly and unblock the artery with the help of catheters. During the so-called mechanical thrombectomy, a lot of data has to be recorded and then transferred to various registers. Dr. Nils Lehnen, senior physician at the Clinic for Diagnostic and Interventional Neuroradiology and Pediatric Neuroradiology at the University Hospital Bonn (UKB), has now discovered in a study that ChatGPT could be a great help in this data transfer. The results have now been published in the specialist journal Radiology. When did the patient arrive, when was a CT scan performed, when was the first puncture, when could the blood flow be restored,… During mechanical thrombectomy, a range of data must be recorded in the patient report and then manually transferred to various registers for the clinical outcome and for prospecti
Source: www.dicardiology.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1Information Technology’s Impact on Tomorrow’s Health - 6 day(s) ago
The Healthcare Information and Management Systems Society (HIMSS) Global Health Conference and Exhibition brought together more than 30,000 professionals including public health officials, CIOs, CTOs, informaticists, data scientists and practitioners in Orlando, March 11-15, for the latest in education, with nearly 500 speakers presenting education sessions, as well as plenty of innovation and collaboration, all in keeping with the theme of “Creating Tomorrow’s Health.” More than 1,000 exhibiting companies filled the exhibit hall of the Orange County Convention Center, where they showcased cutting-edge technology, and presented innovative products and services. Driving Transformational Change Through Sustainability During the opening keynote session, “Personalizing the Patient Experience: Harnessing the Power of AI to Drive Real Transformational Change,” the session discussed how, due to an increased demand to reduce administrative burdens, increasing operational efficiencies and leve
Source: www.dicardiology.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
April 30, 2024 — The expanding use of transcatheter technologies has changed the landscape in the treatment of valvular disease in adult cardiac patients, with valve surgery rapidly shifting to more complex interventions frequently involving other concomitant procedures. To inform heart team and patient decision-making on valve surgery, The Society of Thoracic Surgeons (STS) has launched new risk calculators for isolated tricuspid valve repair and replacement; surgical aortic valve replacement (SAVR) after prior transcatheter aortic valve replacement (TAVR); and multi-valve surgery with or without coronary artery bypass grafting (CABG). The STS rolled out all three interactive, mobile-friendly risk calculators in April 2024, adding to its existing portfolio of risk calculators for adult cardiac surgery. “As cardiothoracic surgery continues to evolve, STS has responded by adding new risk models to guide treatment decisions and benchmark performance,” said STS President Jennifer C. Roma
Source: www.dicardiology.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0Advance in the Treatment of Acute Heart Failure Identified - 7 day(s) ago
April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death. The drug, dapagliflozin, was initially approved for the treatment of Type 2 diabetes, but it since has been shown to reduce the risk of hospitalization for heart failure and death in patients with serious health problems that include heart and chronic kidney disease and heightened cardiovascular risk. Reporting this month in the Journal of the American College of Cardiology, the researchers found that dapagliflozin also benefits patients after admission to the hospital for acute heart failure. The drug improves diuresis, the elimination of excess fluid from the lungs, thereby relieving congestion, and it can reduce hospital stays. “We demonstrated safety and efficacy of initiating dapagliflozin within the first day of hospitalization
Source: www.dicardiology.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 0
April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. However, the risk of arrhythmias following this procedure is reportedly high. In a recent study, researchers from Japan tested a novel approach that involves injecting ‘cardiac spheroids,’ cultured from human stem cells, directly into damaged ventricles. The highly positive outcomes observed in primate models highlight the potential of this strategy. Cardiovascular diseases are still among the top causes of death worldwide, and especially prevalent in developed countries. Myocardial infarctions, commonly known as “heart attacks,” are on the rise, resulting in a significant number of deaths each year. Heart attacks typically kill millions of cardiac muscle cells, leaving the heart in a weakened state. Since mammals cannot regenerate cardiac muscle cells on their own, heart transplants are currently the only clinically viable option for patien
Source: www.dicardiology.comCategories: General Medicine News, CardiologistsTweet
@DAICeditor @biocardia BioCardia announced the primary endpoint results of the open label roll-in cohort of the #CardiAMP #CellTherapy in #Chronic #Myocardial_Ischemia Trial. https://t.co/8L2YJmOXtr